Related Experiment Video
Updated: Jul 23, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Acute Meningitis
1Department of Neurology, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, D-81377 Munich, Germany.
Abstract:
Recent major epidemiologic trends in bacterial meningitis include a dramatic decline in the incidence of Haemophilus influenzae meningitis since the introduction of the protein-conjugated H. influenzae vaccines, and a worldwide increase in infections with antibiotic-resistant strains of bacterial pathogens. Cases of meningitis caused by resistant strains require an alternative therapeutic strategy. Animal studies have identified inflammatory mediators, eg, chemokines, excitatory amino acids, and endothelins, which are involved in the pathophysiology of bacterial meningitis. There is increasing evidence that reactive oxygen species (ROS), reactive nitrogen species, peroxynitrite, and matrix metalloproteinases contribute to brain damage during bacterial meningitis. The cytotoxic effects of ROS and peroxynitrite include the initiation of lipid peroxidation and the induction of DNA single-strand breakage. Damaged DNA activates poly(ADP-ribose) polymerase (PARP). Recent experimental data suggest that lipid peroxidation and PARP activation play a role in the development of meningitis-associated intracranial complications and brain injury. Agents that interfere with the production of ROS and peroxynitrite, and interfere with lipid peroxidation and PARP activation, may represent novel, therapeutic strategies by which meningitis-associated brain damage can be limited, therefore improving the outcome of this serious disease.
Insights
Bacterial meningitis treatment is challenged by antibiotic resistance. Targeting reactive oxygen species (ROS) and poly(ADP-ribose) polymerase (PARP) may limit brain damage and improve outcomes.
Area of Science:
- Neuroscience
- Infectious Diseases
- Pharmacology
Background:
- Bacterial meningitis incidence is declining due to vaccines, but antibiotic-resistant strains are increasing.
- Pathophysiology involves inflammatory mediators, reactive oxygen species (ROS), reactive nitrogen species, and matrix metalloproteinases.
- ROS and peroxynitrite contribute to brain damage via lipid peroxidation and DNA damage, activating poly(ADP-ribose) polymerase (PARP).
Purpose of the Study:
- To explore novel therapeutic strategies for bacterial meningitis.
- To investigate the role of ROS, peroxynitrite, lipid peroxidation, and PARP activation in meningitis-associated brain injury.
- To identify agents that can limit brain damage and improve patient outcomes.
Main Methods:
- Review of animal studies on bacterial meningitis pathophysiology.
- Analysis of inflammatory mediators, ROS, reactive nitrogen species, and their cytotoxic effects.
- Examination of the role of lipid peroxidation and PARP activation in brain injury.
Main Results:
- Reactive oxygen species (ROS) and peroxynitrite induce lipid peroxidation and DNA single-strand breakage.
- DNA damage activates poly(ADP-ribose) polymerase (PARP).
- Lipid peroxidation and PARP activation are implicated in meningitis-associated intracranial complications and brain injury.
Conclusions:
- Agents targeting ROS and peroxynitrite production may offer novel therapeutic strategies.
- Interfering with lipid peroxidation and PARP activation could limit meningitis-associated brain damage.
- Novel therapeutic approaches targeting these pathways may improve outcomes for bacterial meningitis.
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Brain Abscess l: Introduction

